Methods for Nucleic Acid Mapping and Identification of Fine Structural Variations in Nucleic Acids
OwnerSi Lokinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerSi Lokinventor
Estimating the term…
An in vitro, extracellular method of juxtaposing sequence tags (GVTs) where two constituent members of a tag pair (GVT-pair) are unique positional markers of a defined separation distance and/or are markers of nucleic acid positions that demarcate adjacent cleavage sites for one or more different restriction endonucleases along the length of a plurality of target nucleic acid molecules, the method comprising: Fragmenting the target nucleic acid molecule to form target DNA insert; ligating a DNA adaptor having one or more restriction endonuclease recognition sites to both ends of a fragmented target DNA insert and the ligation of the adaptor-ligated target DNA insert to a DNA backbone to create a circular molecule; digesting the adaptor using a restriction endonuclease at the recognition site to cleave the target DNA insert at a defined distance from each end thereof to create two sequence tags (GVTs) comprising terminal sequences of the target DNA insert that are attached to the linear DNA backbone; and recircularizing the linear DNA backbone with the attached GVTs to obtain a circular DNA molecule including a GVT pair having two juxtaposed GVTs; GVT-pair DNA is recovered by nucleic acid amplification.
An in vitro, extracellular method of juxtaposing sequence tags (GVTs) where two constituent members of a tag pair (GVT-pair) are unique positional markers of a defined separation distance in a plurality of target nucleic acid molecules, the method comprising:
An in vitro, extracellular method of juxtaposing sequence tags (GVTs) where the two constituent members of a tag pair are unique positional markers of two adjacent and cleavable restriction endonuclease sites of one or more restriction endonucleases along the length of a plurality of target nucleic acid molecules, the method comprising:
The method of claim L, wherein the type III restriction endonuclease is used to create the GVT is Pst II.
Dependencies are inferred from the claim text.